• Home

  • Documents

  • mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8,...
29

mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6

  • Upload
    others

  • View
    11

  • Download
    0

Embed Size (px)

Citation preview

Page 1: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 2: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 3: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 4: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 5: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 6: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 7: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 8: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 9: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 10: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 11: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 12: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 13: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 14: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 15: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 16: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 17: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 18: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 19: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 20: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 21: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 22: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 23: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 24: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 25: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 26: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 27: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 28: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6
Page 29: mg/ ms o. 097 mg/ mg o. 036 fix • O O 0. 10mg/m3 C mg/ 364 8, 713 0.014 0 0.0 T. 360 364 8, 686 8, 716 o. 013 o. 014 o o o. o. o o 0.0 0.0 mg/ ms 0/0 362 8,699 0.014 0 0.0 6

Quantum chemical molecular modellingmichalak/mmod2008/L2.pdf · Input dataInput data atoms zmatrix 1 H 0 0 0 0.0 0.0 0.0 2 O 1 2 0 0.99 0.0 0.0 3 H 2 1 3 0.99 105.0 0.0 end basis

Quantum chemical molecular modellingmichalak/mmod2008/L2.pdf · Input dataInput data atoms zmatrix 1 H 0 0 0 0.0 0.0 0.0 2 O 1 2 0 0.99 0.0 0.0 3 H 2 1 3 0.99 105.0 0.0 end basis

Documents
H2( q dH L#Õ >%,FÂ ¹ B 27 º Ø4# Z'¼Fû6õFéG Â …>%,FÂ ¹ B 27 º Ø4# Z'¼Fû6õFéG Â qFþFïG Fþ&k 8Fþ1* %Ê'2 FÃH $0¯ H 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

H2( q dH L#Õ >%,FÂ ¹ B 27 º Ø4# Z'¼Fû6õFéG Â …>%,FÂ ¹ B 27 º Ø4# Z'¼Fû6õFéG Â qFþFïG Fþ&k 8Fþ1* %Ê'2 FÃH $0¯ H 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Documents
1.5 > 1.0 0.5 0.0 Poly (I:C) (h) O 1.5 1.0 o- 0.5 0.0 Poly ... · 1.5 > 1.0 0.5 0.0 Poly (I:C) (h) O 1.5 1.0 o- 0.5 0.0 Poly (I:C) (h) 1 0 3 1 6 3 9 6 12 BV2 cells p62 LC3 (SE) LC3

1.5 > 1.0 0.5 0.0 Poly (I:C) (h) O 1.5 1.0 o- 0.5 0.0 Poly ... · 1.5 > 1.0 0.5 0.0 Poly (I:C) (h) O 1.5 1.0 o- 0.5 0.0 Poly (I:C) (h) 1 0 3 1 6 3 9 6 12 BV2 cells p62 LC3 (SE) LC3

Documents
UNIVERSITY OF NEBRASKA–LINCOLN INSTITUTIONAL …Studies 1/-- -- -- 0 0.0 0 0.0 -- -- -- 0 0.0 0 0.0 56 3 -- -56 0.0 -3 0.0 56 3 0 -56 0.0 -3 0.0 Journalism & Mass Communications

UNIVERSITY OF NEBRASKA–LINCOLN INSTITUTIONAL …Studies 1/-- -- -- 0 0.0 0 0.0 -- -- -- 0 0.0 0 0.0 56 3 -- -56 0.0 -3 0.0 56 3 0 -56 0.0 -3 0.0 Journalism & Mass Communications

Documents
c c O E c c c co co c O c O O z - vinmonarki.sevinmonarki.se/H dynamis.pdf · c c O E c c c co co c O c O O z 880-301 z O o 0.0 c O 0.0 0.0 Q.) z o o . Title: Foto pÃ¥ helsida Author:

c c O E c c c co co c O c O O z - vinmonarki.sevinmonarki.se/H dynamis.pdf · c c O E c c c co co c O c O O z 880-301 z O o 0.0 c O 0.0 0.0 Q.) z o o . Title: Foto pÃ¥ helsida Author:

Documents
Legislative Finance Divisionlegfin.akleg.gov/BudgetAnalysisTools/LY2017/DOR... · FY2013 Replace Interagency Receipts with CIP Receipts FndChg 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0

Legislative Finance Divisionlegfin.akleg.gov/BudgetAnalysisTools/LY2017/DOR... · FY2013 Replace Interagency Receipts with CIP Receipts FndChg 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0

Documents
SITE PHOTOMECTRIC PLAN E-1 · 2018. 10. 17. · 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

SITE PHOTOMECTRIC PLAN E-1 · 2018. 10. 17. · 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Documents
o E 0.0 00 cd 00 o 0.0 0 z - Sentoria...Created Date 11/26/2013 9:06:34 AM

o E 0.0 00 cd 00 o 0.0 0 z - Sentoria...Created Date 11/26/2013 9:06:34 AM

Documents
NEUDIAVALL 150 mg/g 0.0 - MEVET · 2019. 4. 3. · Amoxicilina trihidrato COMPOSICIÓN POR g Sustancia activa: Amoxicilina (trihidrato) 150 mg Excipientes: Harina de cáscara de almendra

NEUDIAVALL 150 mg/g 0.0 - MEVET · 2019. 4. 3. · Amoxicilina trihidrato COMPOSICIÓN POR g Sustancia activa: Amoxicilina (trihidrato) 150 mg Excipientes: Harina de cáscara de almendra

Documents
fileaûOLOPATADlNE 0.0% EYE DROP IN ML 6înOLOPATADINE HCL 0.0% W/V EYE DROP IN t' ML ... valproate sodium doo mg powder and solvent for solution for injection, 6) vial ... ãûPlRENOXINF

fileaûOLOPATADlNE 0.0% EYE DROP IN ML 6înOLOPATADINE HCL 0.0% W/V EYE DROP IN t' ML ... valproate sodium doo mg powder and solvent for solution for injection, 6) vial ... ãûPlRENOXINF

Documents
tatijo - transparencia.df.gob.mxtransparencia.df.gob.mx/work/sites/vut/resources/LocalContent/1628… · 223.4) O. 0.0 0.0 0.0 0 0.0 20Mal 22. 4 JUD ›C RECURSO EX101 [EN ha0 PROTESTA

tatijo - transparencia.df.gob.mxtransparencia.df.gob.mx/work/sites/vut/resources/LocalContent/1628… · 223.4) O. 0.0 0.0 0.0 0 0.0 20Mal 22. 4 JUD ›C RECURSO EX101 [EN ha0 PROTESTA

Documents
2 Julio Receta. Arroz Oriental - FUTEJE · Carbohidratos (g) 19.6 Fibra (g) 2.1 Colesterol (mg) 0.0 Sodio (mg) 85.2 Comentario nutricional: Las calabacitas son gran fuente de potasio,

2 Julio Receta. Arroz Oriental - FUTEJE · Carbohidratos (g) 19.6 Fibra (g) 2.1 Colesterol (mg) 0.0 Sodio (mg) 85.2 Comentario nutricional: Las calabacitas son gran fuente de potasio,

Documents
Buss. Principles Ad. & P Compen. Corp.Tax Mgmt Indian ... 015 calvin john pinto 0.0 0.0 0.0 0.0 0.0 0.0 ... 91 100 sujata barman 4.0 6.0 0.0 0.0 4.0 ... 96 105 vartika sharma 4.0 0.0

Buss. Principles Ad. & P Compen. Corp.Tax Mgmt Indian ... 015 calvin john pinto 0.0 0.0 0.0 0.0 0.0 0.0 ... 91 100 sujata barman 4.0 6.0 0.0 0.0 4.0 ... 96 105 vartika sharma 4.0 0.0

Documents
MEB KAHRAMANMARAŞ - TÜRKOĞLU İLÇE MİLLÎ EĞİTİM …...Ç.HASANAGA 0.0/ YOLDERESi 0.0 G.O.P. 0.0/ KADIOGLU ÇiFLiGi 0.0 YESiLYÖRE 0.0/ DOLUCA SHT.ALi CAN 0.0 ÇEYREK FINAL

MEB KAHRAMANMARAŞ - TÜRKOĞLU İLÇE MİLLÎ EĞİTİM …...Ç.HASANAGA 0.0/ YOLDERESi 0.0 G.O.P. 0.0/ KADIOGLU ÇiFLiGi 0.0 YESiLYÖRE 0.0/ DOLUCA SHT.ALi CAN 0.0 ÇEYREK FINAL

Documents
םינותנ דסמ יתביבס-ילכלכ · 2017. 6. 5. · 3 0.0 2.8 Pb 0.1 0.0 0.1 0.0 0.0 Formaldehyde 0.1 0.0 0.0 1_3_Butadien 0.0 - - 0.0 0.0 0.0 0.0 0.0 ... 3 2,095 2,721

םינותנ דסמ יתביבס-ילכלכ · 2017. 6. 5. · 3 0.0 2.8 Pb 0.1 0.0 0.1 0.0 0.0 Formaldehyde 0.1 0.0 0.0 1_3_Butadien 0.0 - - 0.0 0.0 0.0 0.0 0.0 ... 3 2,095 2,721

Documents
static-content.springer.com10.1186... · 2018-04-16 · 1 Chroococcidiopsis sp. ATCC 27900 2.3% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%

static-content.springer.com10.1186... · 2018-04-16 · 1 Chroococcidiopsis sp. ATCC 27900 2.3% 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%

Documents
B&H ENGINEERS · 2020. 3. 7. · 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

B&H ENGINEERS · 2020. 3. 7. · 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Documents
DS-brochure-2019 · 2020. 6. 12. · 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Overall Accura 92.13% 0.0% 0.0% 0.0% 0.0% 0.0% 3.7% 96.3% 0.0% 96.6% 0.0% 3.4% 0.0% . Title: DS-brochure-2019

DS-brochure-2019 · 2020. 6. 12. · 100.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% Overall Accura 92.13% 0.0% 0.0% 0.0% 0.0% 0.0% 3.7% 96.3% 0.0% 96.6% 0.0% 3.4% 0.0% . Title: DS-brochure-2019

Documents
ANEXO I FICHA TÉCNICA O RESUMEN DE LAS ......1,4 mg / 0,36 mg o 2,9 mg / 0,71 mg al día. Se puede administrar un comprimido adicional de Zubsolv 1,4 mg / 0,36 mg o 2,9 mg / 0,71

ANEXO I FICHA TÉCNICA O RESUMEN DE LAS ......1,4 mg / 0,36 mg o 2,9 mg / 0,71 mg al día. Se puede administrar un comprimido adicional de Zubsolv 1,4 mg / 0,36 mg o 2,9 mg / 0,71

Documents
Simple tools for assessing the value of nature · Hard surfaces 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Land-cover score matrix

Simple tools for assessing the value of nature · Hard surfaces 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Land-cover score matrix

Documents
cd 0.0 o o o o 00 o o < o o o o +-.oooo 010 00 00 o 00 0 0.2 OK E E … · 2016-09-14 · cd 0.0 o o o o 00 o o < o o o o _+-.oooo 010 00 00 o 00 0 0.2 OK E E E 00 0 1-4 .õ 0 0.0

cd 0.0 o o o o 00 o o < o o o o +-.oooo 010 00 00 o 00 0 0.2 OK E E … · 2016-09-14 · cd 0.0 o o o o 00 o o < o o o o _+-.oooo 010 00 00 o 00 0 0.2 OK E E E 00 0 1-4 .õ 0 0.0

Documents
0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 Haddy DE Show Stables ... Stepping Stone Farm Cari Gleeson 0.0 0.0 0.0 30.0 22.0 0.0 0.0 0.0 52.0 So Money AJ Roller Maggie Brink 12.0 30.0 0.0 0.0

0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.0 Haddy DE Show Stables ... Stepping Stone Farm Cari Gleeson 0.0 0.0 0.0 30.0 22.0 0.0 0.0 0.0 52.0 So Money AJ Roller Maggie Brink 12.0 30.0 0.0 0.0

Documents
0.0-Pravilnik o Min.vodi

0.0-Pravilnik o Min.vodi

Documents
kiha21.or.kr · 102.0 100 mg, 65 100 mo (1000 mg/L) 20, 60, 80 mg/L RI 0.0 20.0 60.0 80.0 STD Blank STD 1 STD 2 STD 3 0.0 20.4 61.2 81.6 Zl- 0.5 test tubeÕll 250 ,uQ, 500 — -r-

kiha21.or.kr · 102.0 100 mg, 65 100 mo (1000 mg/L) 20, 60, 80 mg/L RI 0.0 20.0 60.0 80.0 STD Blank STD 1 STD 2 STD 3 0.0 20.4 61.2 81.6 Zl- 0.5 test tubeÕll 250 ,uQ, 500 — -r-

Documents
auxilium-fundacja.org.plauxilium-fundacja.org.pl/wp-content/uploads/2013/06/ScaloneDokum… · 51675.8 51675.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51675.8 263.4 0.0 0.0 0.0 0.0 263.4 0.0

auxilium-fundacja.org.plauxilium-fundacja.org.pl/wp-content/uploads/2013/06/ScaloneDokum… · 51675.8 51675.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 51675.8 263.4 0.0 0.0 0.0 0.0 263.4 0.0

Documents
Template for series Acta Universitatis Ouluensis · Web viewTIC (mg l-1) 1.6 8.5 29 3.3a 0.0 7 5.1 4.0 4 SiO2 (mg l-1)4.2 13.0 29 11.6 5.2 11 16.8 6.5 8 6.7a 49.2 7 15.0 0.0 4 Cl-

Template for series Acta Universitatis Ouluensis · Web viewTIC (mg l-1) 1.6 8.5 29 3.3a 0.0 7 5.1 4.0 4 SiO2 (mg l-1)4.2 13.0 29 11.6 5.2 11 16.8 6.5 8 6.7a 49.2 7 15.0 0.0 4 Cl-

Documents
Legislative Finance Division · FY2006 CIP Receipts for Motor Fuel Tax Auditor RSA FndChg 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 The Tax Division enters into an annual reimbursable

Legislative Finance Division · FY2006 CIP Receipts for Motor Fuel Tax Auditor RSA FndChg 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 The Tax Division enters into an annual reimbursable

Documents
 · ill Ill o o c c c 0.0 E c c 0.0 c o o E c o E o u c E E o u

 · ill Ill o o c c c 0.0 E c c 0.0 c o o E c o E o u c E E o u

Documents
A210 EXTERIOR ELEVATIONS · oh 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1

A210 EXTERIOR ELEVATIONS · oh 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1

Documents
タクロリムス...2017/02/21  · 薬剤名 200,000 1,000,000 50,000 150,000 100,000 100,000 40,000 100,000 5,000 8,000 120,000 150,000 500,000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

タクロリムス...2017/02/21  · 薬剤名 200,000 1,000,000 50,000 150,000 100,000 100,000 40,000 100,000 5,000 8,000 120,000 150,000 500,000 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Documents